/

Seaport Therapeutics

Develops oral neuropsychiatric medicines using a proprietary technology platform.

BiotechnologyPharmaceuticals seaporttx.com ↗

Company facts

Founded: 2020
Employees: 62
Headquarters: United States
Type: Private
Funding: Series B · $225M · 2024